𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in the treatment of Hodgkin lymphoma

✍ Scribed by Dennis A. Eichenauer, Andreas Engert

Book ID
120955199
Publisher
Carden Jennings Publishing
Year
2012
Tongue
English
Weight
339 KB
Volume
96
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Results of total body irradiation in the
Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas
✍ Steven C. Carabell; John T. Chaffey; David S. Rosenthal; William C. Moloney; Sam πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 493 KB πŸ‘ 2 views

Total body irradiation (TBI) was used as primary therapy for 58 previously untreated patients with Stage III or IV non-Hodgkin's lymphoma (NHL). 150 rad was administered, with 15 rad fractions twice a week, with careful monitoring of hematologic status. Thrombocytopenia was the most frequent complic

Low dose fractionated whole body irradia
Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma
✍ Noah C. Choi; Adrian R. Timothy; Sheldon D. Kaufman; Robert W. Carey; Alan C. Ai πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 506 KB

Thirty-nine patients with advanced non-Hodgkin's lymphoma (38 patients with lymphocytic lymphoma and 1 patient with mixed lymphocytic and histiocytic lymphoma) were treated by fractionated low dose whole body irradiation (WBI) with a minimum follow-up of 8 months. Twenty-eight patients had no previo

Cladribine in the treatment of advanced
Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma
✍ Anil Tulpule; Gary Schiller; Laura A. Harvey-Buchanan; Myung Lee; Byron M. Espin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## BACKGROUND. Cladribine (2-chlorodeoxyadenosine) is a purine nucleoside analog with cytotoxic activity against both resting and proliferating cells. Clinical studies with cladribine have reported antitumor activity against various hematologic malignancies.